IHSN Survey Catalog
  • Home
  • Microdata Catalog
  • Citations
  • Login
    Login
    Home / Central Data Catalog / LAO_2011_MICS-DHS_V01_M / variable [F4]
central

Social Indicator Survey 2011-2012

Lao PDR, 2011 - 2012
Get Microdata
Reference ID
LAO_2011_MICS-DHS_v01_M
Producer(s)
Ministry of Health, Lao Statistics Bureau, United Nations Children’s Fund
Metadata
DDI/XML JSON
Created on
Feb 19, 2014
Last modified
Mar 29, 2019
Page views
73536
Downloads
1011
  • Study Description
  • Data Dictionary
  • Downloads
  • Get Microdata
  • Related Publications
  • Data files
  • hh
  • hl
  • wm
  • ch
  • mn
  • tn
  • bh
  • mm

Days after fever started first took anti-malarial (ML11)

Data file: ch

Overview

Valid: 25
Invalid: 11233
Type: Discrete
Decimal: 0
Start: 210
End: 210
Width: 1
Range: -
Format:

Questions and instructions

Literal question
How long after the fever started did (name) first take (name of anti-malarial from ML6 or ML9)?
Categories
Value Category
0 Same day
1 Next day
2 2 days after the fever
3 3 days after the fever
4 4 or more days after the fever
8 DK
9 Missing
Sysmiss
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Interviewer instructions
This question asks about the time interval between the beginning of the child's fever and when he/she took the first dose of an anti-malarial medicine to treat the fever.

If multiple anti-malarial medicines are mentioned in ML6 or ML9, name all anti-malarials mentioned. Record the code for the day on which an anti-malarial was given for the first time. If he/she started taking (the anti-malarial) the same day the fever started, circle '0' for 'Same day'. If the anti-malarial was first given the next day (the day after the fever began), circle '1' for 'Next day' and so on. If the respondent does not know how long after the fever started the child first took the anti-malarial, circle '8'.
Back to Catalog
IHSN Survey Catalog

© IHSN Survey Catalog, All Rights Reserved.